DCAF7 downregulation as a potential prognostic biomarker in clear cell renal cell carcinoma: tissue-based and in vitro evidence
DDB1- and CUL4-associated factor 7 (DCAF7) has been demonstrated in protein degradation, transcriptional regulation, and signal transduction in various cancers. However, its prognostic value and celluar function in clear cell renal cell carcinoma (ccRCC) remain to be explored. This study assessed DCAF7 expression and its clinicopathological and prognostic implications in ccRCC utilizing bioinformatics, immunohistochemistry and western blot analysis. Analysis of three independent cohorts (TCGA-KIRC, GSE40435, and the combined dataset GSE53757 and GSE66272) consistently revealed that DCAF7 is downregulated in ccRCC. Further validation through immunohistochemistry and Western blot analysis confirmed the downregulation of DCAF7 protein in samples from ccRCC patients, as well as in ACHN and OS-RC-2 cell lines. Correlation analysis revealed a significant association between decreased DCAF7 expression and higher pathological grades, suggesting that low expression may serve as a predictor of poor prognosis in patients. Receiver operating characteristic (ROC) based on these public tissue cohorts confirmed that DCAF7 mRNA expression discriminates ccRCC tumors from adjacent normal tissue. Multivariate Cox regression analysis identified distant metastasis, lymph node metastasis, and age as independent risk factors, whereas high DCAF7 expression served as an independent protective factor. A nomogram incorporating these prognostic factors effectively predicted overall survival at 1-, 3-, and 5-years. At the CpG-island level, methylation was not significantly correlated with DCAF7 mRNA expression. However, several individual CpG sites showed significantly associations with patient survival. Immune infiltration analysis suggested a positive correlation between DCAF7 expression and the extent of immune cell infiltration. Gene Set Enrichment Analysis (GSEA) further revealed significant enrichment of pathways, including WNT signaling negative regulatory module (SOST/LRP4 axis), RTK-CBL-mediated ubiquitination, and Hippo signaling in the high DCAF7 expression group. In vitro functional assays demonstrated that overexpression of DCAF7 significantly inhibited the proliferation, migration, and invasion of ACHN and OS-RC-2 cells, suggesting a potential tumor-suppressive role of DCAF7 in ccRCC. Collectively, DCAF7 may serve as a prognostic biomarker for ccRCC, and future research is required to validate its translational potential as a therapeutic target.
Authors
- Yanli Liao
- Shengjie Liao (ORCID: https://orcid.org/0000-0003-4584-631X)
- Liang Qin (ORCID: https://orcid.org/0009-0007-3166-7608)
- Qingfeng Shao
- Sitong Chen
- Duanzhuo Li
- Ganjiang Zhou
Institutions
- Zhaoqing University (CN)
- The First People's Hospital of Zhaoqing (CN)
- Zhaoqing Medical College (CN)
Publication Details
- Journal
- Scientific Reports
- Published
- 2026-11-19
- DOI
- https://doi.org/10.1038/s41598-026-81582-y
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00